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Objectives: The purpose of this study was to investigate how the inflow cannulation
site of the left ventricular assist system with a centrifugal pump would influence
cardiac function on failing heart models.
Methods: In 10 sheep, a left ventricular assist system was instituted by an outflow
cannula in the descending aorta, two inflow cannulas in the left atrium and the left
ventricle, and connecting those cannulas to a magnetically suspended centrifugal
pump. A conductance catheter and a tipped micromanometer for monitoring the
pressure-volume loop were also inserted into the left ventricle. Myocardial oxygen
consumption was directly measured. Heart failure was induced by injection of
microspheres into the left main coronary artery. The assist rate was varied from 0%
to 100% at each inflow cannulation site.
Results: The pump flow with left ventricular cannulation increased during the
systolic phase and decreased during the diastolic phase, whereas it was constant with
left atrial cannulation. Ejection fraction with left atrial cannulation decreased as the
assist rate increased, whereas that with left ventricular cannulation was maintained
up to 75% assist. The external work with left atrial cannulation decreased gradually
as the assist rate increased, whereas the external work with left ventricular cannu-
lation did not decrease until the assist rate reached 75%. The myocardial oxygen
consumption in both cannulations decreased proportionally as the assist rate in-
creased; they were significantly less with left ventricular cannulation at the 100%
assist rate than with left atrial cannulation.
Conclusion: Left ventricular cannulation during left ventricular assistance maintains
ejection fraction and effectively reduces oxygen consumption.
The left ventricular assist system (LVAS) helps save patients withprofound heart failure. So far, the LVAS has used mainly pulsatilepumps,1-3 although nonpulsatile pumps such as axial pumps havealso been applied with favorable results.4-7 The magnetically sus-pended centrifugal pump (MSCP) is a type of nonpulsatile centrif-ugal pumps without a shaft.8,9 The impeller of the MSCP is sus-
pended between the walls of the pump casing by magnetic forces and rotates without
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contact inside the casing. We10,11 previously reported that
the MSCP showed long durability and antithrombogenicity
in long-term animal experiments. It is expected that the
MSCP will be used in patients whose failing heart will
recover after long-term assistance, and testing is now at the
preclinical stage.
Recently, there have been several reports of failing hearts
that have recovered after long-term use of the LVAS, which
was removed successfully.12-15 A decrease in the afterload
of a native heart may play an important role in its recovery
after failure.
Nonpulsatile pumps whose flow changes automatically
according to changes in afterload are more advantageous
than pulsatile pumps that are usually operated in an asyn-
chronous mode. Furthermore, the blood drainage site of
LVAS may influence the recovery process.
In our animal studies using MSCP, we inserted an inflow
cannula into the left ventricle (LV) because the pump flow
could be obtained more easily than that from left atrial (LA)
cannulation. Although LV cannulation is commonly used
with pulsatile pumps, that is merely applied with centrifugal
pumps. Some previous studies compared LA versus LV
cannulation during LV assist with pulsatile pumps,16-19
whereas few have examined the use of centrifugal pump.20
The purpose of the present study was to investigate how
the inflow cannulation site of the LVAS using MSCP would
influence cardiac function in failing heart models. The he-
modynamic effects of LV cannulation during use of the
LVAS were compared with those of LA cannulation. To
assess the hemodynamic performance of the LV, we inves-
tigated the pressure-volume loop in the LV in conjunction
with continuous measurement of myocardial oxygen con-
sumption (MVO2).
Methods
Experimental Preparations
Ten sheep weighing from 36 to 48 kg (mean 41  3 kg) were used
in this study. The sheep were anesthetized with an intravenous
Figure 1. Schematic drawing of the experimental preparation. MSCP, Magnetically suspended centrifugal pump;
CS, coronary sinus; PA, pulmonary artery; Ao, aorta; RA, right atrium; LA, left atrium; LV, left ventricle.
Figure 2. Rotational speed of the pump during LVAS at various
assist rates. LAC, Left atrial cannulation; LVC, left ventricular
cannulation; ††P < .01 compared with left atrial cannulation.
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Figure 3. Left ventricular pressure-volume loops during LVAS at various assist rates. A, Left atrial cannulation. B,
Left ventricular cannulation.
Figure 4. Simultaneous measurement of aortic pressure (AP), left ventricular pressure (LVP), and pump flow wave
during LVAS at left atrial cannulation (LAC, top) and left ventricular cannulation (LVC, bottom) at various assist
rates.
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injection of sodium thiopental. They then underwent endotracheal
intubation and were maintained on a ventilator with oxygen mixed
with halothane. After the left thoracotomy with resection of the
fifth and sixth ribs and transverse splitting of the sternum, the left
internal thoracic artery was cannulated for aortic pressure moni-
toring. The hemiazygos vein was ligated, and a reversible occluder
was placed around the inferior vena cava. After heparinization
(200 U/kg), a 10-mm outflow cannula was sutured to the descend-
ing aorta, an inflow cannula (10 mm) was inserted into the LA
appendage, and the cannulas were connected to the inlet and outlet
ports of the MSCP to establish LA-aorta LVAS. During the LVAS,
another inflow cannula (10 mm) was inserted into the LV through
a sutured cuff on the apex. This cannula was connected to the inlet
port with an Y-shaped connector, so that the cannulation site could
be quickly alternated.
A conductance catheter (ANP 455; Sentron, Roden, The Neth-
erlands) and a tipped micromanometer catheter (model SPC-500;
Millar Instruments, Inc, Houston, Tex) for monitoring the pres-
sure-volume loop were also inserted into the LV. All measure-
ments were sampled simultaneously at 333 Hz, stored on a floppy
disk, and analyzed with LYCOM Sigma-5 analyzer (CardioDy-
namics, BV, Zoetermeer, The Netherlands).
Blood flow from the coronary sinus was measured by institu-
tion of a bypass circuit (5 mm) from the coronary sinus via the
hemiazygos vein to the right atrium. The ostium of the coronary
sinus was then doubly ligated, and an oxygen saturation catheter
(Opticath catheter, model P7110-EP-H 7.5F, Abbott Laboratories,
North Chicago, Ill) was inserted into this circuit to continuously
measure coronary sinus oxygen saturation. MVO2 was calculated
by multiplying the oxygen content difference between arterial and
coronary sinus blood by the coronary sinus blood flow and was
standardized by LV weight.
Microspheres numbering 1.8  106 (15 m in diameter, Tech-
polymer; Sekisui, Osaka, Japan) were injected into the left main
coronary artery to induce heart failure according to previous stud-
ies.21-23 Hemodynamic parameters including the ventricular end-
systolic elastance (Emax) were compared before and after injec-
tion of microspheres. Figure 1 is a schematic drawing of the
experimental preparation.
Study Protocol
Before the study protocol was started, the LVAS from both the LA
and the LV cannulation sites were operated at their respective
maximum rotational speeds to decide the maximum pumping flow,
which was defined as the 100% assist rate. After measurement of
the hemodynamic characteristics at the control (0%), the assist rate
was increased in a stepwise fashion to 25%, 50%, 75%, and 100%
of the maximum LV assist flow by alternating between LA and LV
cannulation at each assist rate. The following parameters at each
assist rate were measured: heart rate, rotational speed, systolic
arterial pressure, mean arterial pressure, LV end-systolic pressure,
LV end-diastolic pressure, LV end-systolic volume, LV end-dia-
stolic volume, ejection fraction, external work derived from the
pressure-volume loop, coronary sinus flow, and oxygen saturation
in the coronary sinus. The arterial oxygen saturation was measured
only at control and was regarded as the same throughout the rest of
the protocol. All measurements were recorded during steady-state
conditions for each setting of the assist rate and each cannulation
site. After the end of the experiment, sheep were put to death with
high-dose pentobarbital, and the wet weight of the sheep LV was
recorded.
All animal handling and experiments were conducted to minimize
stress and discomfort to sheep based on guidelines for Animal
Experiments of Kyoto University, which conform to the law on the
Guide for the Care and Use of Laboratory Animals in Japan.
All values were expressed as means  SEM. The variables
were analyzed by repeated-measures analysis of variance
(ANOVA). If the result of the ANOVA was significant, a post hoc
paired t test was performed.
Results
Heart failure developed after injection of microspheres. The
hemodynamic parameters before and after injection of mi-
crospheres are summarized in Table 1. Aortic pressure
decreased and LV end-diastolic pressure increased, while
the end-systolic elastance decreased. The mean value of
maximum pumping flow was 3.56  0.67 L/min and there
was little difference between maximum flow of LA and LV
cannulation. As the assist rate increased in a stepwise fash-
ion, the rotational speed proportionally increased in both
LA and LV cannulation. The rotational speed of LA can-
nulation was higher than that of LV cannulation at each
assist rate except 100% assist (Figure 2). Figure 3 illustrates
the pressure-volume loops of LA and LV cannulation. With
LA cannulation, LV end-diastolic pressure proportionally
decreased as the assist rate increased. With LV cannulation,
LV end-diastolic pressure did not change until 75% assist,
and it decreased at 100% assist. As seen in Figure 4, the
Figure 5. Systolic aortic pressure during LVAS at various assist
rates. SAP, Systolic aortic pressure; MAP, mean aortic pressure;
LAC, left atrial cannulation; LVC, left ventricular cannulation;
*P < .05 compared with no assist (paired t test). Repeated-
measures ANOVA: SAP cannulation: F  4.59, P < .0608; SAP
assist rate: F  1.73, P < .1644; SAP cannulation  assist rate:
F  0.86, P < .4946. MAP cannulation: F  0.01, P  .9445 ; MAP
assist rate: F  13.43, P < .0001; MAP cannulation  assist rate:
F  0.94, P  .4529.
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pump flow with LV cannulation increased during the sys-
tolic phase and decreased during the diastolic phase,
whereas it was constant with LA cannulation.
Systolic and mean arterial pressure gradually increased
as the assist rate increased with both LA and LV cannula-
tion (Figure 5). LV end-diastolic pressure of both groups
decreased as the assist rate increased, whereas LV end-
systolic pressure did not change up to 75% assist, but
showed a slight increase with LA cannulation and a marked
decrease with LV cannulation at 100% assist (Figure 6). In
accordance with the change in the LV end-diastolic and
end-systolic volume during assist, ejection fraction with LA
cannulation decreased as the assist rate increased, whereas
that with LV cannulation was maintained up to 75% assist
(Figure 7). As a consequence of the reduction in LV end-
diastolic volume, external work in the LA cannulation pro-
portionally decreased as the assist rate increased. However,
the external work with LV cannulation did not decrease
until 75% assist rate and decreased equally at 100% assist
(Figure 8). There were significant differences in external
work between LA and LV cannulation at 25%, 50%, and
75% assist rate. In both the LA and LV cannulation, the
MVO2 decreased proportionally as the assist rate increased
in a similar manner. However, the MVO2 at 100% assist
rate was significantly less with LV cannulation (Figure 9).
Discussion
Several controversies have been reported with respect to the
inflow cannulation site during use of the LVAS. The LA
cannula is technically easier to insert and is less invasive
than the LV cannula. On the other hand, LV cannulation is
advantageous in terms of a lower incidence of embolic
episodes and greater pump flow.17,18 In this study, rotational
speeds with LV cannulation were lower than those with LA
cannulation, suggesting that LV cannulation achieved
pumping flow easily because of the increase in preload.
With regard to the effect of myocardial unloading during
use of the LVAS, the cannulation site is important. Pennock
Figure 6. Left ventricular end-systolic pressure (A) and left ventricular end-diastolic pressure (B) during LVAS at
various assist rates. ESP, Left ventricular end-systolic pressure; EDP, left ventricular end-diastolic pressure; LAC,
left atrial cannulation; LVC, left ventricular cannulation; P < .01 compared with left atrial cannulation; *P < .05,
**P < .01 compared with no assist (paired t test). Repeated-measures ANOVA: ESP cannulation: F  77.90, P <
.0001; ESP assist rate: F  36.92, P < .0001; ESP cannulation  assist rate: F  50.11, P < .0001. EDP cannulation:
F  2.58, P  0.1427; EDP assist rate: F  23.48, P < .0001; EDP cannulation  assist rate: F  7.27, P  .0002.
TABLE 1. Hemodynamic parameters before and after injection of microspheres
HR
(bpm)
SAP
(mm Hg)
MAP
(mm Hg)
LVEDP
(mm Hg)
Emax
(mL mm Hg1)
Preinjection 120.6 6.2 87.3 3.6 74.3 4.1 7.7 1.5 5.13 0.15
Postinjection 128.0 9.4 78.3 3.5 64.8 3.5* 14.6 2.1* 2.61 0.18†
Mean  SEM. HR, Heart rate; SAP, systolic aortic pressure; MAP, mean aortic pressure; LVDEP, left ventricular end-diastolic pressure; Emax, end-systolic
elastance.
*P  .05 compared with preinjection.
†P  .01 compared with preinjection (paired t test).
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and associates16 reported that LV cannulation reduced myo-
cardial infarct size more than LA cannulation using a roller
pump. Pantalos and coworkers19 reported that LV cannula-
tion was superior to LA cannulation for myocardial unload-
ing using pulsatile ventricular assist. However, Cohen and
colleagues20 reported that there was no significant differ-
ence between LA and LV cannulation in MVO2 reduction
when a centrifugal pump was used. In interpreting myocar-
dial unloading in relation to cannulation site, the type of
device should be considered. The results of the present
study suggested that LA and LV cannulation reduced the
MVO2 equally up to a 75% assist rate, which was consistent
with the findings of Cohen,20 Kawaguchi,21 Goldstein,24 and
their associates. Although a similar decrease in the MVO2 at
less than 100% assist was observed for both cannulation
sites, we consider that LV cannulation could be advanta-
geous even at 50% and 75% assist because of synchronized
increase in pump output during the systolic phase. Since the
pump flow of centrifugal pumps is inversely correlated with
the pressure difference between inflow and outflow, an
increase in LV pressure results in a decrease in the pressure
difference and eventually an increase in pump flow. During
assist in the systolic phase of the native heart, the LV is
actually unloaded because of the increase in pump flow.
Figure 7. Left ventricular end-systolic volume (A), left ventricular end-diastolic volume (B), and left ventricular
ejection fraction (C) during LVAS at various assist rates. ESV, Left ventricular end-systolic volume; EDV, left
ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LAC, left atrial cannulation; LVC, left
ventricular cannulation; P < .05, P < .01 compared with left atrial cannulation; *P < .05, **P < .01 compared with
no assist (paired t test). Repeated-measures ANOVA: ESV cannulation: F  12.13, P  .0069; ESV assist rate: F 
2.68, P .0472; ESV cannulation assist rate: F 8.49, P < .0001; EDV cannulation: F 1.73, P .2208; EDV assist
rate, F 24.09, P < .0001; EDV cannulation assist rate: F 8.02, P < .0001; LVEF cannulation: F 2.46, P < .1516;
LVEF assist rate: F  8.91, P < .0001; LVEF cannulation  assist rate: F  0.75, P < .5668.
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Thus, during use of the LVAS with a centrifugal pump, LV
cannulation is superior to LA cannulation in terms of myo-
cardial unloading.
Since the external work should correlate with the
MVO2,25 the external work with LA cannulation decreased
linearly between 25% and 75% along with a proportional
reduction in MVO2. In contrast, the external work with LV
cannulation did not decrease proportionally, despite the
same reduction in the MVO2 as that for LA cannulation. In
other words, with LV cannulation there was dissociation
between the external work and the MVO2 at 50% and 75%
assist rates. We infer that this dissociation of external work
and MVO2 is due to the effect of synchronization during the
systolic phase when substantial energy is required. This
effect is applicable only at 50% and 75% and diminishes at
100% full assist because of the predominant venting effect
at this level.
Ejection fraction was also maintained with LV cannula-
tion, consistent with clinical results that were reported for
patients with a pulsatile device.15 Although it remains un-
clear whether better ejection fraction would be important
during LVAS, we speculate that maintaining ejection frac-
tion could prevent disuse atrophy of the heart and might be
advantageous for recovery of the heart. Thus, LV cannula-
tion effectively reduces oxygen consumption without com-
promising cardiac wall motion.
The MSCP used in the present study is one of several
types of centrifugal pumps. It eliminates a shaft and seal and
allows long-term operation. The results of this study are not
uniquely characteristic to the MSCP and would be applica-
ble to any type of centrifugal pump, because all centrifugal
pumps show a similar correlation between pump flow and
the inflow and outflow pressure difference.
Pulsatile assist devices are usually operated in an asyn-
chronous mode with either LA or LV cannulation, although
a synchronous mode is ideal for better myocardial unload-
ing. A synchronous mode with a pulsatile device sometimes
causes inadequate pump flow and necessitates sensing pa-
rameters such as an electrocardiograph. When a centrifugal
pump was used with LV cannulation, the pump flow auto-
matically increased during the systolic phase and decreased
during the diastolic phase, similar to synchronization during
the systolic period as seen in Figure 4. This autosynchro-
nized systolic unloading could eliminate the need for sen-
sors and reduce oxygen consumption, thus improving the
recovery rate of the native heart after long-term assist.
One limitation of this study was that we did not observe
the long-term effect and focused only on the acute phase
during assist. Although hemodynamic effects during the
acute phase would continue in theory, remodeling and
changes at the molecular level during the chronic phase
were unclear. It is not possible to predict when heart failure
will recede and the LVAS can be removed. Another limi-
tation was the model of heart failure we used, that is,
injection of microspheres 15 m in diameter into the cor-
onary arteries. Microspheres of this size cause global isch-
emia and not myocardial infarction. We used this technique
to mimic global cardiac dysfunction that is similar to dilated
cardiomyopathy. However, it was unclear whether this heart
failure model was clinically relevant.
Figure 9. Myocardial oxygen consumption during LVAS at various
assist rates. MVO2, Myocardial oxygen consumption; LAC, left
atrial cannulation; LVC, left ventricular cannulation; P < .01
compared with left atrial cannulation; *P < .05, **P < .01 com-
pared with no assist (paired t test). Repeated-measures ANOVA:
cannulation: F  5.93, P  .0376; assist rate, F  32.16, P < .0001;
cannulation  assist rate: F  7.88, P  .0001.
Figure 8. External work during LVAS at various assist rates. EW,
External work; LAC, left atrial cannulation; LVC, left ventricular
cannulation; P < .05, P < .01 compared with left atrial cannula-
tion; *P < .05, **P < .01 compared with no assist (paired t test).
Repeated-measures ANOVA: Cannulation: F  8.94, P  .0152;
assist rate: F  34.40, P < .0001; cannulation  assist rate: F 
2.09, P  .1029.
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In conclusion, we have investigated the impact of the
inflow cannulation site during use of the LVAS with a
centrifugal pump in a failing heart model. LV cannulation
appears to maintain ejection fraction and provides effective
reduction in oxygen consumption, because the pump flow
increases automatically during the systolic phase and de-
creases during the diastolic phase. This autosynchronized
systolic unloading would obviate the need for any sensors in
the living body and reduce oxygen consumption.
We gratefully acknowledge Mr M. Watanabe at the Takeda
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